Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA – Get Free Report) saw a large decline in short interest in the month of October. As of October 15th, there was short interest totalling 373,700 shares, a decline of 11.4% from the September 30th total of 421,900 shares. Based on an average daily trading volume, of 30,300 shares, the short-interest […]
Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA – Get Rating) was the recipient of a significant drop in short interest during the month of April. As of April 15th, there was short interest totalling 645,100 shares, a drop of 7.7% from the March 31st total of 698,800 shares. Approximately 0.9% of the company’s shares are short sold. Based […]
Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA – Get Rating) was the target of a significant decline in short interest in April. As of April 15th, there was short interest totalling 645,100 shares, a decline of 7.7% from the March 31st total of 698,800 shares. Based on an average trading volume of 245,400 shares, the short-interest ratio is […]